Why ARS Pharmaceuticals, Inc. (SPRY) stock fell 9.5% intraday on Monday, November 2, 2026

ARS Pharmaceuticals, Inc. (SPRY) traded at $3.06 as of 1:31 PM ET, down 9.47% on Monday, November 2, 2026, on volume of 674,032 shares (0.4× its 3-month average); market value about $300.0M.

SPRY was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for SPRY on Monday, November 2, 2026 or the trading day before (October 30, 2026):

• Nov 2, 2026: One of 13 Biotechnology stocks among the day's biggest losers (PGEN, HELP, KRYS, DNA, TWST, MLYS, MDXG, SLS, ABSI, AKTS, BCAX, SPRY, DFTX), with no comparable group among the biggest gainers

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on SPRY

SPRY stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 2, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 10:44 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 10:44 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt